// App-Quantinova.ai

4112 : Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhances aggressiveness in triple-negative breast cancers

Researchers

Presenter

  • Theresa Bonner

Principal Investigators

  • Suryatheja Ananthula

  • Janene Nordan

  • Simran Batth

  • Gailen D. Marshall

  • Lauren H. Gardner

  • Yoshiko Shimizu

  • Wael M. El Shamy

Medical Centers

  • Univ of Mississippi Medcl Ctr, Jackson, MS

  • University of Hawaii, Honolulu, HI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Mesenchymal stem cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved